Libya vs Namibia: Amphetamine use disorder death rate by age
Libya
0 deaths per 100,000 people
in 2021
Namibia
0 deaths per 100,000 people
in 2021
Libya rank
1st
Namibia rank
1st
Amphetamine use disorder death rate by age over time
- Libya
- Namibia
How they compare
Libya currently reports 0 deaths per 100,000 people against 0 deaths per 100,000 people in Namibia, a difference of 0 deaths per 100,000 people.
Across all 22 years both countries report, Namibia has been ahead every year.
Libya ranks 1st and Namibia ranks 1st of 194 countries.
Head to head by decade
| Decade | Libya | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
| 2010s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
| 2020s | 0 deaths per 100,000 people | 0 deaths per 100,000 people | 0 deaths per 100,000 people | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher amphetamine use disorder death rate by age, Libya or Namibia?
- Libya, at 0 deaths per 100,000 people against 0 deaths per 100,000 people in Namibia as of 2021.
- What is the difference in amphetamine use disorder death rate by age between Libya and Namibia?
- 0 deaths per 100,000 people, with Libya ahead.
- How many years of comparable data are there for Libya and Namibia?
- 22 years are reported by both, from 2000 to 2021.
- How do Libya and Namibia rank globally for amphetamine use disorder death rate by age?
- Libya ranks 1st and Namibia ranks 1st of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Amphetamine use disorder death rate by age. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from amphetamine use disorders among both sexes aged 0-4 year olds, per 100,000 people.